American Century Companies’s Abiomed Inc ABMD Stock Holding History

American Century Companies’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-394,233	Closed	-$96.8M	–	2629
2022 Q3	$96.8M	Buy	394,233 +15,812	+4%	+$4.27M	0.09%	262
2022 Q2	$93.7M	Buy	378,421 +220,043	+139%	+$59.4M	0.08%	279
2022 Q1	$52.5M	Sell	158,378 -7,069	-4%	-$2.18M	0.04%	438
2021 Q4	$59.4M	Buy	165,447 +7,771	+5%	+$2.63M	0.04%	432
2021 Q3	$51.3M	Sell	157,676 -26,606	-14%	-$9.01M	0.04%	448
2021 Q2	$57.5M	Sell	184,282 -6,813	-4%	-$2.09M	0.04%	435
2021 Q1	$60.9M	Buy	191,095 +10,356	+6%	+$3.31M	0.04%	401
2020 Q4	$58.6M	Sell	180,739 -97,888	-35%	-$27.1M	0.05%	360
2020 Q3	$77.2M	Buy	278,627 +45,119	+19%	+$13M	0.07%	282
2020 Q2	$56.4M	Buy	233,508 +46,065	+25%	+$9.25M	0.05%	320
2020 Q1	$27.2M	Sell	187,443 -146,078	-44%	-$24.2M	0.03%	404
2019 Q4	$56.9M	Sell	333,521 -81,957	-20%	-$15.2M	0.05%	332
2019 Q3	$73.9M	Sell	415,478 -73,749	-15%	-$15.9M	0.07%	291
2019 Q2	$127M	Buy	489,227 +50,596	+12%	+$13.4M	0.13%	214
2019 Q1	$125M	Buy	438,631 +67,075	+18%	+$22.3M	0.13%	217
2018 Q4	$121M	Buy	371,556 +42,347	+13%	+$14.7M	0.14%	209
2018 Q3	$148M	Sell	329,209 -72,514	-18%	-$28.6M	0.14%	205
2018 Q2	$164M	Sell	401,723 -374,557	-48%	-$136M	0.17%	176
2018 Q1	$226M	Sell	776,280 -187,237	-19%	-$47.5M	0.23%	129
2017 Q4	$181M	Buy	963,517 +479,375	+99%	+$89.5M	0.18%	173
2017 Q3	$81.6M	Buy	484,142 +241,868	+100%	+$36.6M	0.08%	295
2017 Q2	$34.7M	Buy	242,274 +57,468	+31%	+$7.72M	0.04%	422
2017 Q1	$23.1M	Buy	184,806 +90,098	+95%	+$10.4M	0.02%	494
2016 Q4	$10.7M	Buy	94,708 +85,325	+909%	+$9.88M	0.01%	650
2016 Q3	$1.21M	Buy	+9,383	New	+$1.12M	﹤0.01%	1132
2016 Q2	–	Sell	-34,583	Closed	-$3.28M	–	1418
2016 Q1	$3.28M	Sell	34,583 -4,116	-11%	-$347K	﹤0.01%	915
2015 Q4	$3.49M	Buy	38,699 +5,823	+18%	+$494K	﹤0.01%	918
2015 Q3	$3.05M	Buy	+32,876	New	+$2.9M	﹤0.01%	957

Other funds holding ABMD

TRSOTSOK

Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Avion Wealth The Woodlands, Texas $537M AUM 18.24% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

American Century Companies's ABMD Position: Q4 2022 in Review

American Century Companies sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 394,233 shares — an estimated $96.8M sold.

American Century Companies first reported a position in ABMD in Q3 2015 and held it in 28 quarters. The position peaked at $226M in Q1 2018. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

American Century Companies reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
American Century Companies sold 394,233 Abiomed Inc shares in Q4 2022, an estimated $96.8M.
American Century Companies first reported a position in Abiomed Inc in Q3 2015 and held it in 28 quarters.
American Century Companies's Abiomed Inc position peaked at $226M in Q1 2018.
8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on American Century Companies's 13F filing for Q4 2022, filed 13 Feb 2023.